TITLE

Health Policy. Payment for Oncolytics in the United States: A History of Buy and Bill and Proposals for Reform

AUTHOR(S)
Polite, Blase N.; Ward, Jeffery C.; Cox, John V.; Morton, Roscoe F.; Hennessy, John; Page, Ray D.; Conti, Rena M.
PUB. DATE
November 2014
SOURCE
Journal of Oncology Practice;Nov2014, Vol. 10 Issue 6, p357
SOURCE TYPE
Academic Journal
DOC. TYPE
Opinion
ABSTRACT
The authors explore the history of the health policy governing Medicare reimbursement for drugs provided in outpatient oncology practices in the U.S. They emphasize the consequences of the average sales price (ASP)-based model for Medicare reimbursements. They offer proposals to reform the Medicare reimbursement policies.
ACCESSION #
99340961

 

Related Articles

  • International Efforts in Health Care Reform: Systemic Treatment Funding Model Reform in Ontario. Kaizer, Leonard; Simanovski, Vicky; Blais, Irene; Lalonde, Carlin; Evans, William K. // Journal of Oncology Practice;May2014, Vol. 10 Issue 3, p190 

    The author discusses systemic treatment, chemotherapy and biotherapy, in Ontario. Topics discussed include the new systemic treatment funding model (STEM), the planning of cancer services done by the government agency Cancer Care Ontario (CCO), and the annual reports titled Cancer System Quality...

  • Getting Past No in Cancer Care. Kolodziej, Michael // Oncologist;Jul2016, Vol. 21 Issue 7, p782 

    This article examines the potential impact of several proposals for controlling the rapidly increasing costs of cancer care.

  • Promise of Personalized Care Hinges on Reimbursement Reform. Bankhead, Charles // Personalized Medicine in Oncology;May2014, Vol. 3 Issue 3, p162 

    No abstract available.

  • Oncology Care Delivery Reform: Carpe Diem. Kolodziej, Michael // Journal of Oncology Practice;Nov2015, Vol. 11 Issue 6, p468 

    The author discusses the delivery of oncology care reform in the U.S. in 2015. He observes that implementation has been fairly slow, with cultural change needed, that data on outcomes have been few, and that communication challenges among involved parties remain. The author states that the added...

  • Practice Benchmarking in the Age of Targeted Auditing: Radiation Oncology. Langdale, Ryan P.; Holland, Ben F. // Journal of Oncology Practice;Nov2013 Supplement, p45s 

    The frequency and sophistication of health care reimbursement auditing have progressed rapidly in recent years, leaving many oncologists wondering whether their private practices would survive a full-scale government investigation. The Medicare Part B claims database provides a complex but rich...

  • Cost-Savings Measures Will Dot the Oncology Landscape. Kuznar, Wayne // American Health & Drug Benefits;2016Specialissue, Vol. 9, p37 

    The article presents the views of Marie A. Hollowell, senior manager at Zitter Health Insights, on cost savings in areas of oncology as discussed at the Sixth Annual Conference of the Association for Value-Based Cancer Care held in 2016. It reflects on an incarese in risk arrangements with...

  • The Long Battle Over Payment for Oncology Services in the Office Setting. Bailes, Joseph S.; Coleman, Terry S. // Journal of Oncology Practice;Jan2014, Vol. 10 Issue 1, p1 

    The author focuses on the reimbursement system for chemotherapy services in the office setting. The author reflects on the modification of rules proposed by the Medicare in the U.S. to change the payment rules by reducing payments for the drugs. The author discusses the impact of proposed rules...

  • Those Who Pay Have a Say: A View on Oncology Drug Pricing and Reimbursement. Newcomer, Lee N. // Oncologist;Jul2016, Vol. 21 Issue 7, p779 

    Four recommendations are made to address the high costs of cancer therapy: remove coverage mandates from state and federal insurance law, create performance transparency for drug regimens, cap profit margins for administering drugs, and place every patient with a genetic mutation in a clinical...

  • Debt sealing. Barlow, Rick Dana // Healthcare Purchasing News;Sep2011, Vol. 35 Issue 9, p4 

    The author reflects on the impact that the U.S. government's decision to reduce Medicare reimbursement will have on the U.S. health care system and on U.S. health care facilities. He is critical of the decision and suggests that it will not result in cost control and will harm patients and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics